Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. The company is headquartered in Wilmington, Delaware and currently employs 2,960 full-time employees. The firm serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes bio functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Revenue
1,808
482
386
477
463
479
Revenue Growth (YoY)
26%
1%
-5%
7,850%
-15%
6,743%
Cost of Revenue
1,216
325
273
317
301
313
Gross Profit
592
157
113
160
162
166
Selling, General & Admin
291
74
72
76
69
70
Research & Development
53
14
13
13
13
14
Operating Expenses
401
103
99
102
97
99
Other Non Operating Income (Expenses)
-9
-3
-3
1
-4
-4
Pretax Income
-634
20
-15
65
-704
39
Income Tax Expense
51
5
-1
32
15
9
Net Income
-706
16
-12
32
-742
31
Net Income Growth
438.99%
-48%
-93%
-1,167%
-12,467%
--
Shares Outstanding (Diluted)
46
46
46
43
46
47
Shares Change (YoY)
-2%
-2%
-2%
282%
-10%
318%
EPS (Diluted)
-15.34
0.34
-0.26
0.74
-16.13
0.65
EPS Growth
451.99%
-48%
-93%
-374%
-14,763.99%
-1,564%
Free Cash Flow
198
24
95
-7
86
-20
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
32.74%
32.57%
29.27%
33.54%
34.98%
34.65%
Operating Margin
10.56%
11.2%
3.62%
12.15%
14.03%
13.98%
Profit Margin
-39.04%
3.31%
-3.1%
6.7%
-160.25%
6.47%
Free Cash Flow Margin
10.95%
4.97%
24.61%
-1.46%
18.57%
-4.17%
EBITDA
410
69
29
74
80
82
EBITDA Margin
22.67%
14.31%
7.51%
15.51%
17.27%
17.11%
D&A For EBITDA
219
15
15
16
15
15
EBIT
191
54
14
58
65
67
EBIT Margin
10.56%
11.2%
3.62%
12.15%
14.03%
13.98%
Effective Tax Rate
-8.04%
25%
6.66%
49.23%
-2.13%
23.07%
Follow-Up Questions
What are Ashland Inc's key financial statements?
According to the latest financial statement (Form-10K), Ashland Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for ASH?
Ashland Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Ashland Inc's revenue broken down by segment or geography?
Ashland Inc largest revenue segment is Life Sciences, at a revenue of 641,000,000 in the most earnings release.For geography, United States is the primary market for Ashland Inc, at a revenue of 464,000,000.
Is Ashland Inc profitable?
no, according to the latest financial statements, Ashland Inc has a net loss of $0